June 25, 2025

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy

Results from an international clinical trial show that a 14-gene molecular assay can help identify patients with early-stage nonsquamous NSCLC who could benefit from adjuvant chemotherapy after surger...

The ASCO Post

June 25, 2025

I Was Expecting to Hear I Have Heart Disease, Not Cancer

In 2022, I had a computed tomography (CT) coronary calcium scan to see whether there were any signs of narrowing or blockage in my heart arteries. Heart disease runs in my family. My father died of a ...

The ASCO Post

June 24, 2025

AI vs. MDs: Who Navigates the Airways Better?

A new systematic review evaluated 20 studies on artificial intelligence in bronchoscopy and found AI systems often performed as well as or better than human experts in tasks such as airway navigation and lymph node classification.

Conexiant

June 19, 2025

AI Models Predict Lung Cancer Risk Better

A new review finds AI-based models more accurate than traditional regression models at predicting lung cancer risk, especially when using low-dose CT imaging data.

Conexiant

June 19, 2025

Morristown Medical Center First in New Jersey to Offer Nonsurgical Ablation Technique for Advanced Lung Cancer

Atlantic Health System’s Morristown Medical Center is the first hospital in New Jersey to offer patients a new, minimally invasive option to treat advanced lung cancer. The procedure couples technology from the Aliya™ Pulsed Electric Field (PEF) Energy Platform with a robotic Ion Bronchoscopy.

Atlantic Health System

June 18, 2025

NCCN Clinical Practice Guidelines in Oncology: 2025 Updates

The National Comprehensive Cancer Network (NCCN) released its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, covering eight tumor types. Today, guidelines are availa...

The ASCO Post

June 17, 2025

Early-Phase Trial Shows Activity and Safety of Zongertinib in Previously Treated HER2-Mutant NSCLC

Zongertinib, an investigational oral, HER2-selective, EGFR-sparing tyrosine kinase inhibitor, elicited durable responses and demonstrated clinical benefit in patients with advanced, previously treated...

The ASCO Post

June 17, 2025

FDA-Approved Sweetener Found in Vapes

New laboratory analysis found widespread use of neotame, a potent artificial sweetener, in most disposable e-cigarettes sold in the United States, including nicotine-free and nicotine-analogue products.

Conexiant

June 16, 2025

Can Plasma ctDNA Kinetics Predict Response to Systemic Therapy in Advanced NSCLC?

Based on a systematic review and meta-analysis, plasma circulating tumor DNA (ctDNA) kinetics was found to be predictive of survival outcomes in patients with advanced non–small cell lung cancer (NSCL...

The ASCO Post